Dr Mike Leach
Mike Leach M.I.Biol, PhD, Fellow Royal Society of MedicineReader in Pharmacology and Drug Development Room: Grenville 142 Email: m.j.leach@gre.ac.uk Tel: 020 8331 8221 |
 |
Biography
Dr Leach gained his PhD at the Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queens Square, London. He is a Fellow of the Royal Society of Medicine and has a long pedigree in the pharmaceutical industry.
He was a former Section Head at Wellcome Research (now part of GlaxoSmithKline) and much of his career in the pharmaceutical industry centred around searching for treatments for epilepsy such as Lamotrigine; Lamictal™, used in the treatment of both adult and paediatric forms of epilepsy, brain damage after a stroke and more recently, multiple sclerosis (MS). Dr Leach is a co-inventor of Pleneva (BGC20-0134; BTG International) now in Phase II clinical trials for MS.
Dr Leach is also a co-founder of one of the University’s spin out companies- CenTRion Therapeutics, and a member of the School of Science Drug Discovery cluster group.
He is a Fellow of the Royal Society of Medicine; Member of Clinical Neuroscience and Pharmaceutical Medicine and Lipid sections; Journal Referee: Epilepsy Research; Epilepsia; Brain Research; Neuropharmacology; Stroke; Psychopharmacology; and retained contributor to reference text : Antiepileptic Drugs.